uliledlimab (TJD5) / Tracon Pharma, PT Kalbe Farma, I-Mab  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
uliledlimab (TJD5) / I-Mab, Tracon Pharma
NCT03835949: Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

Hourglass Feb 2021 - Dec 2021 : Safety data from trial in combination with TJ004309 for advanced cancer
Active, not recruiting
1
36
US
TJ004309, Atezolizumab
Tracon Pharmaceuticals Inc.
Solid Tumor, Metastatic Cancer
06/22
06/22

Download Options